C15ORF41 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.493000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.110200E-01
Normal-vs-Stage2
7.268800E-01
Normal-vs-Stage3
3.784800E-01
Normal-vs-Stage4
3.865000E-01
Stage1-vs-Stage2
9.219600E-01
Stage1-vs-Stage3
1.901030E-01
Stage1-vs-Stage4
9.819400E-01
Stage2-vs-Stage3
1.900610E-01
Stage2-vs-Stage4
9.508400E-01
Stage3-vs-Stage4
1.594180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.459600E-01
Normal-vs-AfricanAmerican
6.423400E-01
Normal-vs-Asian
7.781800E-01
Caucasian-vs-AfricanAmerican
9.654000E-01
Caucasian-vs-Asian
9.114400E-01
AfricanAmerican-vs-Asian
9.026400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.273200E-01
Normal-vs-Female
7.884000E-01
Male-vs-Female
7.974000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.734200E-01
Normal-vs-Age(41-60Yrs)
6.645200E-01
Normal-vs-Age(61-80Yrs)
8.186600E-01
Normal-vs-Age(81-100Yrs)
6.564600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.890000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.304000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.046800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.275600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.855800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.683800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.617800E-01
Normal-vs-Daily Drinker
7.961200E-01
Normal-vs-Weekly Drinker
9.853800E-01
Normal-vs-Occasional Drinker
6.912400E-01
Normal-vs-Social Drinker
9.341400E-01
Non Drinker-vs-Daily Drinker
7.885400E-01
Non Drinker-vs-Weekly Drinker
5.966200E-01
Non Drinker-vs-Occasional Drinker
9.257400E-01
Non Drinker-vs-Social Drinker
6.134000E-01
Daily Drinker-vs-Weekly Drinker
7.147200E-01
Daily Drinker-vs-Occasional Drinker
7.078400E-01
Daily Drinker-vs-Social Drinker
7.412200E-01
Weekly Drinker-vs-Occasional Drinker
5.406000E-01
Weekly Drinker-vs-Social Drinker
9.384600E-01
Occasional Drinker-vs-Social Drinker
5.315600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.582400E-01
Normal-vs-Grade 2
2.416000E-02
Normal-vs-Grade 3
1.030560E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.934000E-01
Grade 1-vs-Grade 3
2.000200E-01
Grade 1-vs-Grade 4
2.582400E-01
Grade 2-vs-Grade 3
5.810400E-01
Grade 2-vs-Grade 4
2.416000E-02
Grade 3-vs-Grade 4
1.030560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.823200E-01
Normal-vs-NonDiabetic
6.869000E-01
Diabetic-vs-NonDiabetic
2.302400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.456200E-01
Normal-vs-NoPancreatitis
7.890800E-01
Pancreatitis-vs-NoPancreatitis
2.179200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.328400E-01
Normal-vs-N1
7.275600E-01
N0-vs-N1
9.176000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.162400E-01
Normal-vs-TP53-NonMutant
5.682400E-01
TP53-Mutant-vs-TP53-NonMutant
1.260640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
